DCF — SANFORD MEDICAL CENTER - FARGO
Enterprise Value: $-3.1B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-3.1B
Enterprise Value
$-973.0M
PV of Cash Flows
$-2.1B
PV of Terminal Value
$-3.5B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.6B | $-201.5M | -13.0% | $-267.3M | $-243.0M |
| Year 2 | $1.6B | $-191.5M | -12.0% | $-259.3M | $-214.3M |
| Year 3 | $1.7B | $-180.7M | -11.0% | $-250.6M | $-188.3M |
| Year 4 | $1.7B | $-177.6M | -10.0% | $-249.6M | $-170.5M |
| Year 5 | $1.8B | $-178.6M | -10.0% | $-252.7M | $-156.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-3.1B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.5B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.13446699626009814
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5